RECOMBINANT-HUMAN-ERYTHROPOIETIN REDUCES FREE ERYTHROCYTE PROTOPORPHYRIN LEVELS IN PATIENTS ON CHRONIC DIALYSIS

被引：16
|
作者：
PIAZZA, V
VILLA, G
GALLI, F
SEGAGNI, S
BOVIO, G
POGGIO, F
PICARDI, L
SALVADEO, A
机构：
[1] Div. di Nefrologia ed Emodiali, Fondazione Clinica del Lavoro, I-27100 Pavia
来源：
NEPHRON | 1992年 / 61卷 / 01期
关键词：
ERYTHROPOIETIN; HEME; HEMODIALYSIS; PORPHYRINS;
D O I：
10.1159/000186834
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
We studied the significance of free erythrocyte protoporphyrin (FEP) in relation to iron status, aluminum levels and anemia in uremic patients on chronic dialysis. All but 1 patient showed high FEP values closely related to the degree of anemia. Increased FEP levels are due to a defective heme synthesis, not related to iron deficiency or aluminum overload. Treatment of anemia with recombinant human erythropoietin reduced FEP values. We therefore hypothesize that recombinant human erythropoietin ameliorates an enzymatic defect in heme synthesis.
引用
收藏
页码：54 / 57
页数：4
相关论文
共 50 条
  • [21] EXERCISE IN HEMODIALYSIS-PATIENTS AFTER TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    LUNDIN, AP
    AKERMAN, MJH
    CHESLER, RM
    DELANO, BG
    GOLDBERG, N
    STEIN, RA
    FRIEDMAN, EA
    NEPHRON, 1991, 58 (03) : 315 - 319
  • [22] BONE-MARROW FINDINGS BEFORE AND AFTER TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CHRONIC HEMODIALYZED PATIENTS
    AHN, JH
    YOON, KS
    LEE, WI
    SUH, JT
    LEE, TW
    IHM, CG
    KIM, MJ
    CLINICAL NEPHROLOGY, 1995, 43 (03) : 189 - 195
  • [23] RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN CHILDREN RECEIVING CONTINUOUS PERITONEAL-DIALYSIS
    PARCHOUX, B
    BROYER, M
    COCHAT, P
    BURGUET, A
    MENGET, A
    BENOIT, D
    NIVET, H
    FISCHBACH, M
    GEISERT, J
    DABOUT, D
    PEDIATRIE, 1993, 48 (05): : 397 - 401
  • [24] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) ON THE HEMOSTATIC SYSTEM IN CHRONIC-HEMODIALYSIS PATIENTS
    HURAIB, S
    ALMOMEN, AK
    GADER, AMA
    MITWALLI, A
    SULIMANI, F
    ABUAISHA, H
    CLINICAL NEPHROLOGY, 1991, 36 (05) : 252 - 257
  • [25] MULTICENTER STUDY WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    TANAKA, H
    KAN, E
    TAKEGAKI, Y
    INARIBA, H
    YOSHIMOTO, M
    OHNO, Y
    MAEKAWA, M
    TATSUMI, N
    KISHIMOTO, T
    ARTIFICIAL ORGANS, 1993, 17 (04) : 213 - 218
  • [26] INTRAPERITONEAL ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    FRENKEN, LAM
    STRUIJK, DG
    COPPENS, PJW
    TIGGELER, RGWL
    KREDIET, RT
    KOENE, RAP
    PERITONEAL DIALYSIS INTERNATIONAL, 1992, 12 (04): : 378 - 383
  • [27] PHARMACOKINETICS OF INTRAPERITONEAL, INTRAVENOUS, AND SUBCUTANEOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    ATESHKADI, A
    JOHNSON, CA
    OXTON, LL
    HAMMOND, TG
    BOHENEK, WS
    ZIMMERMAN, SW
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (06) : 635 - 642
  • [28] NUTRITIONAL ASSESSMENT IN ANEMIC HEMODIALYSIS-PATIENTS TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    BARANY, P
    PETTERSON, E
    AHLBERG, M
    HULTMAN, E
    BERGSTROM, J
    CLINICAL NEPHROLOGY, 1991, 35 (06) : 270 - 279
  • [29] THE PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN HEMODIALYSIS-PATIENTS
    BROCKMOLLER, J
    KOCHLING, J
    WEBER, W
    LOOBY, M
    ROOTS, I
    NEUMAYER, HH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (06) : 499 - 508
  • [30] COMPARISON OF THE EFFICACY AND TOLERANCE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN BETWEEN INTRAVENOUS AND SUBCUTANEOUS ROUTES IN CHRONIC-HEMODIALYSIS PATIENTS
    RUEDIN, P
    STOERMAN, C
    PECHEREBERTSCHI, A
    LESKI, M
    NEPHROLOGIE, 1992, 13 (02): : 87 - 92
12345